Navigation Links
Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation
Date:7/29/2008

- Unsuccessful Phase III Study Does Not Mean the End of Anti-Amyloid Therapies -

CHICAGO, July 29 /PRNewswire-USNewswire/ -- Results from four studies of potential new treatments for Alzheimer's - even an unsuccessful late stage clinical trial - increase the field's knowledge and point scientists toward advances in therapies for the disease, according to research reported today at the 2008 Alzheimer's Association International Conference on Alzheimer's Disease (ICAD 2008), in Chicago.

The reports included data from:

-- A Phase III trial of tarenflurbil (Flurizan, Myriad), an anti-amyloid therapy, that failed to achieve its primary endpoints.

-- A 12-week, Phase IIa trial of PBT2 (Prana Biotechnology), which reduces the toxic form of amyloid by preventing the interaction of amyloid with copper and zinc in the brain.

-- A 84-week, Phase II trial of methylthioninium chloride (rember(TM), TauRx Therapeutics), a tau aggregation inhibitor that targets toxic tau aggregates, or "tangles." Tangles of tau in the brain are another characteristic hallmark of Alzheimer's.

-- A proof of concept clinical trial in mild Alzheimer's of Souvenaid (Danone Research-Centre for Specialised Nutrition), a "medical food" product that encourages the formation of brain synapses and may reduce beta amyloid.

"While researchers continue to investigate amyloid as a target for Alzheimer's therapies - it is the most mature theory being pursued - we must also examine other potential avenues given the urgency of conquering this disease," said Samuel Gandy, MD, Ph.D., chair of the Alzheimer's Association's Medical and Scientific Advisory Council. "We can't leave any stone unturned if we hope to aid the 5 million people currently living with Alzheimer's and the millions more that will be devastated by this epidemic."

While currently approved treatment options for Alzheimer's offer some relief of symptoms for perhaps a year or two, they do no
'/>"/>

SOURCE Alzheimer's Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Echo Therapeutics Announces Positive Results of a Clinical Study of its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes
2. CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE
3. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008
4. Emisphere Presents Dramatic Clinical Evidence Demonstrating New Approach to Vitamin B12 Supplementation
5. Controversy About Lack of Placebo Group Decline in Alzheimers Clinical Trials
6. Genaera Releases Phase 1 Data and New Preclinical Data on the CNS Function of Trodusquemine (MSI-1436) at CBI Obesity Summit
7. Journal of Clinical Oncology Article Highlights CellSearch(TM) Circulating Tumor Cell Test in Treatment of Metastatic Colorectal Cancer
8. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
9. Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials
10. Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus
11. Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... JOSE, Calif. , May 27, ... (NASDAQ: MXIM ) makes it ... sensor and to monitor or control ... the DS28E80 gamma-radiation-resistant, nonvolatile (NV) 1-Wire® ... for DS28E80: http://www.maximintegrated.com/en/products/digital/memory-products/DS28E80.html ...
(Date:5/27/2015)... WINNIPEG, Manitoba , May 27, 2015 /PRNewswire-USNewswire/ ... American customers, the Canadian International Pharmacy Association ... prescription medications online from licensed Canadian pharmacies. Approximately 64% ... health maintenance medications from a non-U.S. pharmacy due ... medications are not covered under their insurance plan.   ...
(Date:5/27/2015)... , May 27, 2015  Genomic Health, Inc. (Nasdaq: ... Operating Officer and Chief Financial Officer, will present at the ... City on Monday, June 1 at 8:30 a.m. ... subsequently archived webcast of the presentation, go to the  Investor ... .  Please connect to the web site at least 15 ...
Breaking Medicine Technology:Gamma-Radiation-Resistant Memory Provides Calibration and Protects from Unsanitary Reuse in Medical Disposables 2Gamma-Radiation-Resistant Memory Provides Calibration and Protects from Unsanitary Reuse in Medical Disposables 3Canadian International Pharmacy Association (CIPA) Survey of Americans Finds 64% Purchase Medications from Canada Due to Affordability 2Canadian International Pharmacy Association (CIPA) Survey of Americans Finds 64% Purchase Medications from Canada Due to Affordability 3Genomic Health to Present at the Jefferies 2015 Global Healthcare Conference 2Genomic Health to Present at the Jefferies 2015 Global Healthcare Conference 3
... (ERT), (Nasdaq: ERES ), a global provider ... medical device industries, today announced it has filed a ... and Exchange Commission (the "SEC").   While the Company ... offering of securities registered pursuant to the registration statement, ...
... 10, 2010 /PRNewswire-Asia-FirstCall/ -- China Medicine Corporation (OTC Bulletin ... manufacturer, developer and distributor of Western pharmaceuticals, traditional Chinese ... results for the third quarter ended September 30, 2010. ... Performance Revenue decreased 8.4% to $17.6 ...
Cached Medicine Technology:ERT Files Shelf Registration Statement 2China Medicine Reports Third Quarter 2010 Financial Results 2China Medicine Reports Third Quarter 2010 Financial Results 3China Medicine Reports Third Quarter 2010 Financial Results 4China Medicine Reports Third Quarter 2010 Financial Results 5China Medicine Reports Third Quarter 2010 Financial Results 6China Medicine Reports Third Quarter 2010 Financial Results 7China Medicine Reports Third Quarter 2010 Financial Results 8China Medicine Reports Third Quarter 2010 Financial Results 9
(Date:5/27/2015)... NOVAtime Technology, Inc. ( http://www.novatime.com ), ... enterprise organizations, announced today that SanMar Corporation successfully ... time, attendance and point tracking processes for over ... States. , Family-owned since 1971, Seattle-based SanMar ... private label, and mill brands. SanMar supplies apparel ...
(Date:5/27/2015)... In support of a new study ... Journal of American Geriatrics Society about the link between ... Commons OB-GYN P.A . is reiterating the nutritional value ... , To examine the relationship between diet soda intake ... Study of Aging (SALSA) tracked the soda consumption of ...
(Date:5/27/2015)... Little Rock, AR (PRWEB) May 27, 2015 ... and Medix today announce a partnership to provide ... the Medix community. This collaboration seeks to strengthen ... skills measurement through CMSA’s CKP program. The mutually ... focused on identifying individual skills of talent in ...
(Date:5/27/2015)... SAN DIEGO, May 27, 2015 – ... first healthcare provider along the Gulf Coast to ... (CCM). In partnership with MD Revolution, a digital ... new program that enables healthcare providers to easily ... This new, user-friendly program is designed to improve ...
(Date:5/27/2015)... 2015 CompanionDx announced that ... genomic analysis in personalized cancer therapy: Non-small cell lung ... Society of Clinical Oncology (ASCO) as part of their ... , The molecular and clinical data used for the ... database. The study reports improved patient outcomes from a ...
Breaking Medicine News(10 mins):Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 2Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 3Health News:Recent Study About the Link Between Diet Sodas and Abdominal Fat Reinforces Bedford Commons OB-GYN's Recommendation to Drink Plenty of Water 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 3Health News:Memorial Hospital Selects MD Revolution's Digital Health Platform to Deliver a New Form of Chronic Care Management 2Health News:Memorial Hospital Selects MD Revolution's Digital Health Platform to Deliver a New Form of Chronic Care Management 3Health News:CompanionDx® Analyzes Non-small Cell Lung Cancer Data for Personalized Cancer Therapy 2Health News:CompanionDx® Analyzes Non-small Cell Lung Cancer Data for Personalized Cancer Therapy 3
... A coalition of concerned consumer advocate groups, including ... called on the New York State Legislature today to ... gifts to doctors. This ban would exclude prescription drug ... gifts valued at over fifty dollars. Pharmaceutical companies, in ...
... a wholly-owned subsidiary of Omron Healthcare, Inc.BANNOCKBURN, Ill., ... leading marketer of blood pressure monitors in North ... of M&M Medi-Medics, S.A. De C.V., a privately-held ... "Omron Healthcare is excited about this ...
LOS ANGELES, Feb. 5 The Killeen Furtney Group, a Los Angeles marketing and public relations firm, announced today that their client, Ms. Nadya Suleman, mother of octuplets born last week, has selecte...
... finds , , THURSDAY, Feb. 5 (HealthDay News) -- ... adequately protected by existing federal government regulation, according ... Health Insurance Portability and Accountability Act (HIPAA) privacy ... authors said. They called on Congress to approve ...
... has provided critical insight into the genetic factors related to ... study, published by Cell Press in the February 6th issue ... to have a profound impact on the future design of ... cells (LSCs) were initially described as rare cells that share ...
... about the lawOLYMPIA, Wash., Feb. 5 The number of ... 2006, according to a new report. The annual rate of ... from nine percent in 2007 and five percent in 2006. ... is working with other state and local agencies to expand ...
Cached Medicine News:Health News:Consumer Advocates Call on Legislature to Support Governor's Ban on Pharmaceutical Gifts to Doctors 2Health News:Consumer Advocates Call on Legislature to Support Governor's Ban on Pharmaceutical Gifts to Doctors 3Health News:Omron Healthcare, Inc. Acquires M&M Medi-Medics, S.A. De C.V. 2Health News:Private Health Care Info Needs Better Safeguards 2Health News:Leukemia stem cells have more in common with embryonic stem cells than adult stem cells 2Health News:More Retailers Selling Tobacco to Minors 2Health News:More Retailers Selling Tobacco to Minors 3
...
... Instant-View LH Ovulation Predicting Test is a ... Luteinizing Hormone (hLH) in human urine to ... regulated by the elevation of human luteinizing ... the period starts, hLH has a brief, ...
... The Shandon Varistain 24-4 is ... designed to offer simplicity and ... staining applications. It is desinged ... and continuous throughput. The ...
The Shandon Linistain GLX Linear Stainer is an economical mid-size linear stainer featuring 28 staining stations and a heater/dryer with fume control by a charcoal filter....
Medicine Products: